Results 321 to 330 of about 162,707 (386)

Harnessing nanomaterials to precisely regulate the immunosuppressive tumor microenvironment for enhanced immunotherapy

BMEMat, EarlyView.
The immunosuppressive tumor microenvironment, characterized by hypoxia, redox imbalance, elevated interstitial fluid pressure, and acidity, was comprehensively elucidated. This review discussed the etiology and consequences of the characteristics of the immunosuppressive tumor microenvironment, and analyzed the recent advancements in nanomaterials for ...
Wen Zhang, Xueyin Hu, Wei Cheng, Lumeng Zhang, Yuanfang Chen, Qinrui Fu, Luntao Liu, Saijun Fan   +7 more
wiley   +1 more source

Optic nerve glioma successfully treated with definitive intensity-modulated radiotherapy in a limited-resource setting: a case report. [PDF]

Ecancermedicalscience
Tackie JNO, Schandorf E, Bankah P, Gbadamosi H, Daniels J, Dadzie MA.   +5 more
europepmc   +1 more source

Establishment of a prognosis-related predictive model for hepatocellular carcinoma patients with macrovascular invasion treated with transcatheter arterial chemoembolization combined with intensity modulated radiotherapy. [PDF]

Transl Cancer Res
Yang D, Tian W, Wang W, Zhao X, Wang C, Ma Z.   +5 more
europepmc   +1 more source

Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery for Resectable Pancreatic Cancer: A Retrospective Cohort Study. [PDF]

Ann Surg Oncol
Yamane K, Anazawa T, Nagai K, Kasai Y, Masui T, Izuwa A, Kurahashi K, Ishida S, Ogiso S, Yoshimura M, Iwai T, Matsubara J, Fukuda A, Isoda H, Hidaka Y, Ibi Y, Hatano E.   +16 more
europepmc   +1 more source

Clinical significance of intensity-modulated radiotherapy (IMRT) to the distant metastatic lymph nodes for metastatic cervical cancer. [PDF]

BMC Cancer
Fang C, Liu S, Xia J, Wu X, Zhu J, Ke G.
europepmc   +1 more source

Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study. [PDF]

BMC Cancer
Mou Y, Liang P, Cheng X, He X, Zhang J, Liu L, Liu Q.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial

Journal of Clinical Oncology, 2021
PURPOSE Postoperative Adjuvant Radiation in Cervical Cancer (PARCER), a phase III randomized trial, compared late toxicity after image-guided intensity-modulated radiotherapy (IG-IMRT) with three-dimensional conformal radiation therapy (3D-CRT) in women ...
S. Chopra, Sudeep Gupta, S. Kannan, T. Dora, R. Engineer, A. Mangaj, A. Maheshwari, T. Shylasree, J. Ghosh, S. Paul, R. Phurailatpam, M. Charnalia, Mitali Alone, J. Swamidas, U. Mahantshetty, K. Deodhar, R. Kerkar, S. Shrivastava   +17 more
semanticscholar   +1 more source

Durability of the parotid‐sparing effect of intensity‐modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: A 15‐year follow‐up of a randomized prospective study of IMRT versus two‐dimensional radiotherapy

Head and Neck, 2021
The durability of improved xerostomia with intensity‐modulated radiotherapy (IMRT) in patients with early stage nasopharyngeal carcinoma (NPC) is uncertain.
D. Poon, M. Kam, David Johnson, F. Mo, M. Tong, A. Chan   +5 more
semanticscholar   +1 more source